Literature DB >> 16769440

High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004.

Jose L Sanchez1, Catherine S Todd, Christian T Bautista, Boulos A E Botros, Mumtoz M Khakimov, Guzal M Giyasova, Shavkat K Yakubov, Mukhabat A Abdulaeva, Maghdi D Saad, Ross R Graham, Jean K Carr, Kenneth C Earhart.   

Abstract

OBJECTIVES: To determine HIV prevalence and potential associations with sociodemographic and behavioral factors among injection drug users (IDUs) in Tashkent, Uzbekistan.
METHODS: Subjects in this cross-sectional study provided sociodemographic and risk behavior data and were tested for HIV antibody with a saliva-based enzyme-linked immunosorbent assay (ELISA), followed by saliva-based Western blot confirmation.
RESULTS: Among the 701 IDU subjects enrolled, 209 (29.8%) were diagnosed with HIV infection, HIV infection was more likely among those unemployed (adjusted odds ratio [AOR]=1.47); whose first drug of abuse was heroin (AOR=2.21) or opium poppy extract (AOR=1.61); with a prior history of hepatitis (AOR=1.39); and those who reported never using condoms (AOR=1.65). Independent risk factors associated with HIV infection were heroin as the first illicit drug of abuse, prior hepatitis, lack of condom use, and unemployment.
CONCLUSIONS: Heroin use, sexual transmission, and high unemployment seem to play important roles in HIV transmission. Implementation of effective harm reduction strategies is critical to control the expansion of the HIV epidemic in this country as well as in this region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769440     DOI: 10.1016/s0376-8716(06)80003-7

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

1.  Reconstruction of the Genetic History and the Current Spread of HIV-1 Subtype A in Germany.

Authors:  Kirsten Hanke; Nuno Rodrigues Faria; Denise Kühnert; Kaveh Pouran Yousef; Andrea Hauser; Karolin Meixenberger; Alexandra Hofmann; Viviane Bremer; Barbara Bartmeyer; Oliver Pybus; Claudia Kücherer; Max von Kleist; Norbert Bannert
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

2.  Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; M Raza Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Drug Policy       Date:  2010-12-10

3.  Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.

Authors:  Mark H Kuniholm; Malvina Aladashvili; Carlos Del Rio; Ketavan Stvilia; Nino Gabelia; Rohit A Chitale; Tengiz Tsertsvadze; Kenrad E Nelson
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

4.  Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan.

Authors:  Chris Beyrer; Zeenat Patel; Julie A Stachowiak; Farida K Tishkova; Mark A Stibich; Lindsay M Eyzaguirre; Jean K Carr; Vladimir Mogilnii; Alena Peryshkina; Alisher Latypov; Steffanie A Strathdee
Journal:  AIDS Res Hum Retroviruses       Date:  2009-09       Impact factor: 2.205

5.  Drug use and harm reduction in Afghanistan.

Authors:  Catherine S Todd; Naqibullah Safi; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2005-09-07

6.  HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan.

Authors:  Catherine S Todd; Abdullah M S Abed; Steffanie A Strathdee; Paul T Scott; Boulos A Botros; Naqibullah Safi; Kenneth C Earhart
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

7.  HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy.

Authors:  Emma Jolley; Tim Rhodes; Lucy Platt; Vivian Hope; Alisher Latypov; Martin Donoghoe; David Wilson
Journal:  BMJ Open       Date:  2012-10-18       Impact factor: 2.692

8.  HIV Risks, Testing, and Treatment in the Former Soviet Union: Challenges and Future Directions in Research and Methodology.

Authors:  Victoria M Saadat
Journal:  Cent Asian J Glob Health       Date:  2016-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.